QA: Harrow INC in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001360214_2016_Harrow_INC.pdf

Logs

Graph

Absolute values for 0001360214, Harrow INC

  xvar xval
0 AssetsCurrent 5,873,000
1 IntangibleAssetsNetIncludingGoodwill 5,601,000
2 PropertyPlantAndEquipmentNet 2,657,000
3 remainder_Assets 0
4 LiabilitiesCurrent 5,374,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 10,142,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 17,560,196
9 ResearchAndDevelopmentExpense 395,637
10 remainder_Expenses 52,742,361
11 remainder_Revenues 49,982,413
12 remainder_NetIncome -1,019,023
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 14,131,000
1 Liabilities 15,516,000
2 Expenses 70,698,194
3 Revenues 49,982,413
4 StockholdersEquity -1,385,000
5 NetIncome -21,734,804
6 ComprehensiveNetIncome -21,734,804
7 BaseVar 75,673,315
8 EconomicCapitalRatiobeforeLimitedLiability -1.67
9 EconomicCapitalRatio 1.13

Edgar->Model Mapping

Feature Distribution

Change over Time